Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2016.06.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Repurposing Metformin for Cancer Treatment: Current Clinical Studies

Oncotarget
Oncology
2016English

Cationic Amphiphilic Macromolecule (CAM)–lipid Complexes for Efficient siRNA Gene Silencing

Journal of Controlled Release
Pharmaceutical Science
2014English

Repurposing Metformin for the Prevention of Cancer and Cancer Recurrence

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Lipopolysaccharide Neutralization by Cationic-Amphiphilic Polymers Through Pseudoaggregate Formation

English

Design and Evaluation of New pH-sensitive Amphiphilic Cationic Lipids for siRNA Delivery

Journal of Controlled Release
Pharmaceutical Science
2013English

A Novel Biomarker for Cellular Toxicity and Phospholipid Accumulation by Cationic Amphiphilic Drugs

CHROMATOGRAPHY
2016English

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Frontiers in Medicine
Medicine
2017English

CSACI Position Statement: Newer Generation H1-Antihistamines Are Safer Than First-Generation H1-Antihistamines and Should Be the First-Line Antihistamines for the Treatment of Allergic Rhinitis and Urticaria

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2019English

Repurposing Pilocarpine Hydrochloride for Treatment of Candida Albicans Infections

mSphere
MicrobiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy